Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies

키워드

참고문헌 (40)

1. Colten HR, "Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem" (2006), National Academies Press
2. Nomura K, "Impact of insomnia on individual health dissatisfaction in Japan, South Korea, and Taiwan", Sleep, 28, pp.1328~1332 (2005)[DOI]
3. Ancoli-Israel S, "Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I", Sleep, 22(Suppl 2), pp.S347~S353 (1999)
4. Morin CM, "Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors", Sleep Med, 7, pp.123~130 (2006)[DOI]
5. Mellinger GD, "Insomnia and its treatment: prevalence and correlates", Arch Gen Psychiatry, 42, pp.225~232 (1985)[DOI]
6. Ohayon MM, "Psychotropic medication consumption patterns in the UK general population", J Clin Epidemiol, 51, pp.273~283 (1998)[DOI]
7. Vermeeren A, "Residual effects of hypnotics: epidemiology and clinical implications", CNS Drugs, 18, pp.297~328 (2004)[DOI]
8. Alvarenga JM, "Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambui Health and Aging Study (BHAS)", Rev Bras Psiquiatr, 30, pp.7~11 (2008)
9. Sanna E, "Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes", Eur J Pharmacol, 451, pp.103~110 (2002)[DOI]
10. Inagaki T, "Adverse reactions to zolpidem: case reports and a review of the literature", Prim Care Companion J Clin Psychiatry, 12, pp.e1~e8 (2010)
11. Mailliet F, "Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in Wistar rats", Psychopharmacology (Berl), 156, pp.417~426 (2001)[DOI]
12. Jehle J, "Mechanisms of zolpideminduced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells", Br J Pharmacol, 168, pp.1215~1229 (2013)[DOI]
13. Kim DH, "Comparative anticancer effects of flavonoids and diazepam in cultured cancer cells", Biol Pharm Bull, 31, pp.255~259 (2008)[DOI]
14. [URL]
15. Mallon L, "Is usage of hypnotics associated with mortality?", Sleep Med, 10, pp.279~286 (2009)[DOI]
16. Higgins JP, "Quantifying heterogeneity in a meta-analysis", Stat Med, 21, pp.1539~1558 (2002)[DOI]
17. DerSimonian R, "Meta-analysis in clinical trials", Control Clin Trials, 7, pp.177~188 (1986)[DOI]
18. Merlo J, "Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics: results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden", Eur J Clin Pharmacol, 49, pp.261~265 (1996)[DOI]
19. Zhou X, "Use of non-benzodiazepine hypnotics is associated with decreased risk of coronary artery disease", Intern Med, 51, pp.829~832 (2012)[DOI]
20. Mallon L, "Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population", J Intern Med, 251, pp.207~216 (2002)[DOI]
21. Belleville G, "Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey", Can J Psychiatry, 55, pp.558~567 (2010)[DOI]
22. Rod NH, "Psychosocial risk factors and heart failure hospitalization: a prospective cohort study", Am J Epidemiol, 174, pp.672~680 (2011)[DOI]
23. Jaussent I, "Hypnotics and mortality in an elderly general population: a 12-year prospective study", BMC Med, 11, pp.212~ (2013)[DOI]
24. Lan TY, "The use of hypnotics and mortality: a population-based retrospective cohort study", PLoS One, 10, pp.e0145271~ (2015)[DOI]
25. Sofi F, "Insomnia and risk of cardiovascular disease: a meta-analysis", Eur J Prev Cardiol, 21, pp.57~64 (2014)[DOI]
26. Vogelzangs N, "Cardiovascular disease in persons with depressive and anxiety disorders", J Affect Disord, 125, pp.241~248 (2010)[DOI]
27. Roest AM, "Anxiety and risk of incident coronary heart disease: a meta-analysis", J Am Coll Cardiol, 56, pp.38~46 (2010)[DOI]
28. Huang MP, "Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats", Behav Brain Res, 210, pp.54~66 (2010)[DOI]
29. Price JF, "Risk factors and the sex differential in coronary artery disease", Epidemiology, 8, pp.584~591 (1997)[DOI]
30. Gensini GF, "Classical risk factors and emerging elements in the risk profile for coronary artery disease", Eur Heart J, 19(Suppl A), pp.A53~A61 (1998)
31. Virmani R, "Risk factors in the pathogenesis of coronary artery disease", Compr Ther, 24, pp.519~529 (1998)
32. Lapane KL, "Is the use of psychotropic drugs associated with increased risk of ischemic heart disease?", Epidemiology, 6, pp.376~381 (1995)[DOI]
33. Muzet A, "Benzodiazepine hypnotics increase heart rate during sleep", Sleep, 5, pp.256~261 (1982)[DOI]
34. Hojer J, "Management of benzodiazepine overdose", CNS Drugs, 2, pp.7~17 (1994)[DOI]
35. Ickowicz S, "Benzodiazepine use as an independent risk factor for HIV infection in a Canadian setting", Drug Alcohol Depend, 155, pp.190~194 (2015)[DOI]
36. Kingery JR, "Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania", Heart, 102, pp.1200~1205 (2016)[DOI]
37. Bach P, "Benzodiazepine use and hepatitis C seroconversion in a cohort of persons who inject drugs", Am J Public Health, 106, pp.1067~1072 (2016)[DOI]
38. Domont F, "Chronic hepatitis C virus infection, a new cardiovascular risk factor?", Liver Int, 36, pp.621~627 (2016)[DOI]
39. Bild DE, "Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)", Circulation, 111, pp.1313~1320 (2005)[DOI]
40. deLemos AS, "Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol", Circulation, 106, pp.1321~1326 (2002)[DOI]

관련 논문AI추천